GH and Cardiovascular Risk Factors

Clinical trial NCT01877512 · COMPLETED

Trial details

NCT number: NCT01877512
Sponsor: Amsterdam UMC, location VUmc
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Growth Hormone Deficiency Cardiovascular Diseases Metabolic Syndrome Cognition Physical Activity

Start date: 2013-05-01
Primary completion: 2014-04-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.